Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Stable to launch mainnet v1.3.0 upgrade on May 13

Stable to launch mainnet v1.3.0 upgrade on May 13

ForesightNewsForesightNews2026/05/06 08:32
Show original

Foresight News reports that Stable announced the mainnet v1.3.0 upgrade will be activated on May 13 at 15:00 (UTC+8), at block height 24,077,500. This version focuses on strengthening execution security and improving network consistency, enhancing protection for precompiled execution, EVM execution fixes and consistency, as well as RPC reliability improvements. According to the official statement, this upgrade is mandatory and not backward compatible. Node operators must complete the upgrade before the specified deadline to avoid potential issues such as deposit and withdrawal processes.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The second wave of energy price increases is looming! European Central Bank’s Lane warns: eurozone inflation will be higher and more persistent

Philip Lane, Chief Economist of the European Central Bank, stated that a new round of high energy prices means inflation in the eurozone will remain elevated for longer than the ECB initially anticipated.

智通财经2026/09/22 07:56

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11